PATENT CLAIM ANALYSIS

Application Number: 15941519
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "133100"]

Abstract:
The present invention relates to antibodies against human CD19 (anti-human CD19 antibodies), methods for their production, pharmaceutical compositions containing these antibodies, and methods of using the same.

Claim (Index 10):
A bispecific antibody which specifically binds to human CD19 and to a second antigen, wherein the antibody comprises\n (a) CDR-L1 comprising the amino acid sequence of SEQ ID NO: 43, (b) CDR-L2 comprising the amino acid sequence of SEQ ID NO: 44, (c) CDR-L3 comprising the amino acid sequence of SEQ ID NO: 45, (d) CDR-H1 comprising the amino acid sequence of SEQ ID NO: 46, (e) CDR-H2 comprising the amino acid sequence of SEQ ID NO: 47, and (f) CDR-H3 comprising the amino acid sequence of SEQ ID NO: 48.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 90.0
- Lexical Diversity: 1.22222
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15067024', '15087405', '14839911', '15280379', '14358797']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7275450970582702
- 35 USC 102 Novelty (BERT): 0.510999869638201
- Combined Prediction Score: 0.7058905743162633
- Mean Citation Score: 298.329466
- Max Citation Score: 311.01608
- Similarity Product: 256.9461013636875

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test